(6th August, 2014); Central Drugs Standard Control Organization (CDSCO) ensuring uniform procedures in regulatory inspection for issuance of Certificates of Pharmaceutical Products (COPP) and other Good Manufacturing Practices (GMP) inspections. These procedures were discussed in 47^th Drugs consultative committee (DCC) meeting.

(5th August, 2014); It is known that data related to antibiotics consumption is not maintained in India. And truly it is hard to obtain such data when everything is mess up around. But it is of utmost importance to capitalize such data to fight with microbial resistance. The concern is growing for antimicrobial resistance in pathogens on account of increased availability and use of antibiotics across the country meant for human, animal and industrial consumption.

(29th July, 2014); Looking at the current regulatory environment of clinical trial in India, it is important that all information related to 4 major domains i.e, Sponsor/ CRO, Investigator, Ethics Committee, Patient of clinical trials are captured through online in an organized manner. Hence, for ensuring transparency and faster dissemination of information about clinical trials, health ministry may start information technology (IT) enabled platform. The recommendation of such platform is provided by Prof. Ranjit Roy Chaudhary Committee.

(24th July, 2014); Health Ministry prohibits the manufacture, sale and distribution of fixed dose combination (FDC) of Flupenthixol and Melitracen for human use on recommendations of the Drugs Technical Advisory Board (DTAB).